BROLUCIZUMAB for Choroidal neovascularisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 102 adverse event reports in the FDA FAERS database where BROLUCIZUMAB was used for Choroidal neovascularisation.
Most Reported Side Effects for BROLUCIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Visual impairment | 116 | 17.0% | 0 | 7 |
| Vision blurred | 106 | 15.5% | 0 | 13 |
| Eye pain | 81 | 11.9% | 0 | 4 |
| Vitreous floaters | 74 | 10.9% | 0 | 2 |
| Vitritis | 65 | 9.5% | 0 | 4 |
| Ocular hyperaemia | 62 | 9.1% | 0 | 4 |
| Off label use | 62 | 9.1% | 3 | 1 |
| Subretinal fluid | 62 | 9.1% | 0 | 0 |
| Retinal vasculitis | 52 | 7.6% | 0 | 5 |
| Eye inflammation | 50 | 7.3% | 0 | 6 |
| Visual acuity reduced | 50 | 7.3% | 0 | 6 |
| Uveitis | 48 | 7.0% | 0 | 5 |
| Blindness | 44 | 6.5% | 0 | 4 |
| Product use in unapproved indication | 38 | 5.6% | 0 | 0 |
| Drug ineffective | 36 | 5.3% | 1 | 1 |
Other Indications for BROLUCIZUMAB
Neovascular age-related macular degeneration (225)
Product used for unknown indication (85)
Age-related macular degeneration (73)
Polypoidal choroidal vasculopathy (70)
Diabetic retinal oedema (57)
Macular degeneration (34)
Retinal vein occlusion (29)
Diabetic retinopathy (6)
Other Drugs Used for Choroidal neovascularisation
AFLIBERCEPT (2,953)
RANIBIZUMAB (1,364)
FARICIMAB\FARICIMAB-SVOA (306)
BEVACIZUMAB (302)
BROLUCIZUMAB-DBLL (104)
FARICIMAB-SVOA (65)
VERTEPORFIN (42)
AVASTIN (12)
LUCENTIS (11)
TRIAMCINOLONE ACETONIDE (10)